Search Peptipedia.
Ask a question or explore a peptide. Read a plain-language explanation, then follow its sources for more detail.
Explore the research.
14 source papersOriginal source papers
GLP-1 Receptor Agonists as Emerging Modulators of Inflammation and Angiogenesis in Chronic Cutaneous Wound Healing.
GLP-1 Receptor Agonists Alleviate Diabetic Kidney Injury via β-Klotho-Mediated Ferroptosis Inhibition.
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists.
Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism.
Negative allosteric modulation of the glucagon receptor by RAMP2.
Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment.
Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases.
The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome.
GLP-1 and GIP receptor signaling in beta cells - A review of receptor interactions and co-stimulation.
GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models.
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential.
Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist.
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist.
GLP-1 Receptor Signaling in Astrocytes Regulates Fatty Acid Oxidation, Mitochondrial Integrity, and Function.